Jaguar Health has a new Anreize for the Nasdaq Listing Rule 5635 and

SAN FRANCISCO, CA / ACCESSWIRE / October 11, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or “Unternehmen”) goes to the future, which is the Unternehmen with Wirkung on October 7, 2024 80,000 Restricted Stock Units (RSUs) and new Mitarbeiter 1 and 15,000 RSUs on the four new new Mitarbeiter ( “neue Mitarbeiter 2-5”) weighted hat.

The RSUs for the new Mitarbeiter 1 were delivered in three years, depending on the delivery date on the date of installation of the new Mitarbeiter 1. The RSUs for the new Mitarbeiter 2-5 were removed a year later on the Mitarbeiters’ setup date.

The RSUs for all new functions would be given as Anreiz for the Annahme a description by the use of the Unternehmen and the Vergütungsausschuss des Vorstands von Jaguar genehmigt. The Unverfallbarkeit of the RSUs depends on the new Mitarbeiter until the jewel Unverfallbarkeitterminen weiterhin at Jaguar-tätig ist.

About the Jaguar Health Human Resources Family

Jaguar Health, Inc. (Jaguar) is a pharmaceutical company that has won the new company, which has won a new company, which is engaged in an extremely active field of work namely Sind, zu dem Symptom wie Chronic lähmender Durchfall, Harndrang, Darminkontinenz und krampfartige Schmerzen gehören. The Jaguar family business Napo Pharmaceuticals (Napo) has specialized in the development and sale of medical care products for people for the undisturbed care and management of gastrointestinal symptoms with more complizierten diseases. Napo’s Crofelemer is FDA approved under the brand name Mytesi^® for the symptomatic prevention of non-infection during treatment with HIV/AIDS under antiretroviral therapies. The Jaguar family of Napo Therapeutics is an Italian Unternehmen Jaguar, which was founded in 2021 in Mailand, Italy, and thus receives the help of the crofelemer in Europe and deals with the selection of selene and/or other selene krankheiten concentrates. Jaguar Animal Health is a trade name of Jaguar. Magdalena Biosciences, a joint venture of Jaguar and Filament Health Corp., working with Jaguar’s Entheogen Therapeutics Initiative (ETI), has developed a new drug that has made huge gains in healthcare delivered.

More information about:

Jaguar Health, see https://jaguar.health

Napo Pharmaceuticals, see www.napopharma.com

Napo Therapeutics, located at napotherapeutics.com

Magdalena Biosciences, see magdalenabiosciences.com

Zukunftsgerichtte Aussagen

Bestimmte Aussagen in dieser Pressemitteilung set “zukunftsgerichtte Aussagen” dar. In einigen Fällen können Sie zkunftsgerichtte Aussagen en Begriffen wie “können”, “werden”, “solllten”, “erwarten”, “planen”, “anstreben”, “antizipieren”, “könnten”, “beabsichtigen”, “anstreben”, “projizieren”, “erwägen”, “glauben”, “schätzen”, “vorhersagen”, “potenziell” or “fortsetzen” or the Verneinung dieser Begriffe or others ähnlichen Ausdrücken recognise. When the focused print is handled on the printing press, it is completely in the foreground. Jaguar hat, which has these functions, is based on its active operation and predictions about such an honor. These unused options are now on the date of the press conference and a journey of risks, uncertainties and annahmen, some of which cannot previously be determined or quantified, and one of Jaguar’s controls lie. While the factory does not have a Jaguar factory, the information contained therein is used to activate their activities or revidiers, they are new information, zukünftiger Ereignisse, geänderter Umstände or other Gründen.

Quelle: Jaguar Health, Inc.

Please contact:

[email protected]

Jaguar JAGX

QUELLE: Jaguar Health, Inc.

Watch the original press conference on accesswire.com